Spinocerebellar ataxia type 6, often shortened to SCA6, is a rare, late-onset, autosomal dominant disorder. Like other spinocerebellar ataxias it is characterized by dysarthria, abnormal eye movements, peripheral neuropathy and ataxia of gait, stance and limbs that arise from cerebellar dysfunction. The dysfunction is permanent and progressive, which separates it from episodic ataxia type 2, although some families show a mix of both patterns. Unlike other types, SCA6 is not fatal. It is caused by mutations in CACNA1A, a gene encoding a calcium channel subunit, usually CAG trinucleotide repeat expansions that yield proteins with long stretches of glutamine and a tendency to clump inside cells. Symptoms typically begin between ages 43 and 52, and diagnosis is by genetic testing. Physical therapy and speech pathology help patients manage symptoms.
Facts
Classification
ICD-10 ChapterVI: Diseases of the Nervous System 1 Communicable or Non-communicable Causative Agent
Causative Agent (category) Sources
1. Spinocerebellar ataxia type 6 (Wikipedia)
Signs and symptoms
SCA6 is typified by progressive and permanent cerebellar dysfunction.
Lead
SCA6 is caused by mutations in CACNA1A, a gene encoding a calcium channel
Lead [disease-category]
Spinocerebellar ataxia type 6 (SCA6) is a rare, late-onset, autosomal dominant disorder
lead sentence 1
Spinocerebellar ataxia type 6 (SCA6) is a rare, late-onset, autosomal dominant disorder, which, like other types of SCA, is characterized by dysarthria, oculomotor disorders, peripheral neuropathy, and ataxia of the gait, stance, and limbs due to cerebellar dysfunction.
View the SourceReader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.